X

Unjha Formulations Ltd. Stock Analysis

Small Cap
Evaluated by 181 users | BSE: 531762 | NSE: |
Pharmaceuticals & Drugs
Unjha Formulations (U-For), incorporated in 1987, is the sister concern of Urvesh Psyllium Industries Limited. U-For is the pharmaceuticals manufacturing unit, which is going to various category of formulation like tablet, capsule, oral liquids, injectables (SVP) and powder section to...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Capital Employed 5.36%6.78%46.03%77.9%36.21%45.63%44.7%24.91%22.8%23.29%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 4.45.956.68.910.412.211.311.410.6
Y-o-Y Gr. Rt.-33.6%-15.9%33.3%34.5%16.1%18%-7.7%1.1%-7.2%
Adjusted EPS (Rs.) 0.220.180.20.280.390.570.660.590.670.68
Y-o-Y Gr. Rt.--18.2%11.1%40%39.3%46.2%15.8%-10.6%13.6%1.5%
Book Value per Share (Rs.) 0.93-0.44-0.27-0.040.350.931.592.173.364.05
Adjusted Net Profit 0.10.10.10.10.20.30.30.30.30.3
Net Op. Cash Flow (Rs. Cr.) 0.22.10.50.5-0.70.40.40.1-0.10.4
Debt to Cash Flow from Ops 12.050.1300-0.5700.12000
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Unjha Formulations Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 10.2%3.5%-4.7%-7.2%
Adjusted EPS 13.4%11.8%1%1.5%
Book Value per Share 17.863.236.620.5
Share Price 11.1% 1% -9.1% 23.4%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Equity (%) -181.87566.19124.7575.8357.1849.5437.1424.4322.0418.39
Operating Profit Margin (%) 4.372.643.262.542.13.513.093.032.622.34
Net Profit Margin (%) 2.621.381.821.871.952.482.412.322.622.88
Debt to Equity -9.62-1.33002.5300.06000
Working Capital Days 2421568985745751656361
Cash Conversion Cycle 39-20-112-108-65-40-29-36-26-13
Entity Percentage Holding
Promoters 36.92%
Institutions 0.02%
Non-Institutions 63.05%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Unjha Formulations's performance infers:

Unjha Formulations earnings have grown by 11.8%, whereas share price has appreciated 1% CAGR over the past five years, indicating the company's share price is likely undervalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Unjha Formulations share prices over the last 10 years. Here is what we found out:

Unjha Formulations share price has appreciated 5.3% annually over the past ten years.

Unjha Formulations (U-For), incorporated in 1987, is the sister concern of Urvesh Psyllium Industries Limited. U-For is the pharmaceuticals manufacturing unit, which is going to various category of formulation like tablet, capsule, oral liquids, injectables (SVP) and powder section to manufacture ayurvedic as well as allopathy products.

Fibron Powder & Fibron Sugar Free Powder are the branded ayurvedic products of the company, based on psyllium husk. The products met with an

Unjha Formulations (U-For), incorporated in 1987, is the sister concern of Urvesh Psyllium Industries Limited. U-For is the pharmaceuticals manufacturing unit, which is going to various category of formulation like tablet, capsule, oral liquids, injectables (SVP) and powder section to manufacture ayurvedic as well as allopathy products.

Fibron Powder & Fibron Sugar Free Powder are the branded ayurvedic products of the company, based on psyllium husk. The products met with an overwhelming success in our domestic market. The products mainly caters to somewhat sophisticated market segment who is conscious about their health and at the same time are very particular about various flavour like Orange, Lemon, Lime & Mango taste of the product.

Fibron Powder & Fibron SF powder offer excellent value for the money. Speed U - for could able to promote Fibron Powder & Fibron Powder SF at a most competitive price without sacrificing on quality mainly because their sister concern unit Urvesh Psyllium Industries Ltd. is one of the largest raw material supplier and processor of plyllium in the world. It may be important to note here that even Glaxo India Ltd, Proctor & Gamble, Nicholas Piramal India Ltd are the company's most valued costumers.

The company has entered into an agreement with Nicholas Piramal India for sale of Isabgol Husk based product `Tybogel` and Morepen Laboratories for sale of Dr.Mopren Sat Isabgol.

Urvesh Psyllium Industries Limited is the leading processor and exporter of Psyllium Husk & Powder in India.The company is in this line of business since last 52 years (i.e. from 1949). Initially it processed and supplied Psyllium products in local market but, looking to the worldwide demand, in 1966 it started to export Psyllium Products in the name of Rajendra Brothers. Later on with the increase of demand from overseas buyers there rose a need to expand the business, and thus Urvesh Psyllium Industries was formed in 1985, which later on was converted into a Limited Company in the year 1995.

Product range of the company includes:

  • Fibron Powder
  • Fibron Sugar Free Powder
  • Psyllium Capsules

Achievements/ recognition:

  • GMP & ISO:9001-2000 certified unit.
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback